Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma Group (MREO) Revenue: 2017-2024

Historic Revenue for Mereo BioPharma Group (MREO) over the last 8 years, with Dec 2024 value amounting to -$1.4 million.

  • Mereo BioPharma Group's Revenue rose 177.05% to $272,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$307,000, marking a year-over-year decrease of 5216.67%. This contributed to the annual value of -$1.4 million for FY2024, which is 113.70% down from last year.
  • Per Mereo BioPharma Group's latest filing, its Revenue stood at -$1.4 million for FY2024, which was down 113.70% from $10.0 million recorded in FY2023.
  • In the past 5 years, Mereo BioPharma Group's Revenue ranged from a high of $49.2 million in FY2021 and a low of -$9.8 million during FY2020.
  • For the 3-year period, Mereo BioPharma Group's Revenue averaged around $1.5 million, with its median value being -$1.4 million (2024).
  • Per our database at Business Quant, Mereo BioPharma Group's Revenue spiked by 603.72% in 2021 and then crashed by 113.70% in 2024.
  • Yearly analysis of 5 years shows Mereo BioPharma Group's Revenue stood at -$9.8 million in 2020, then surged by 603.72% to $49.2 million in 2021, then slumped by 108.49% to -$4.2 million in 2022, then spiked by 339.52% to $10.0 million in 2023, then plummeted by 113.70% to -$1.4 million in 2024.